Tubidy
    Automation of cell therapy manufacturing processes - with Jon Ellis, Invetech

    Automation of cell therapy manufacturing processes - with Jon Ellis, Invetech

    37:23 |
    Download MP3

    Related Videos

    Manufacturing & Logistics in Cell Therapies I In The Stem Cell Jungle 2:08

    Manufacturing & Logistics in Cell Therapies I In The Stem Cell Jungle

    Stem Cell Therapy for Diabetes: Current Trials l In the Stem Cell Jungle l Albert Hwa 2:17

    Stem Cell Therapy for Diabetes: Current Trials l In the Stem Cell Jungle l Albert Hwa

    What does the C-Stem™ platform bring to the cell therapy field? 1:46

    What does the C-Stem™ platform bring to the cell therapy field?

    Stem Cell Therapies for Diabetes - In The Stem Cell Jungle with Albert Hwa 52:03

    Stem Cell Therapies for Diabetes - In The Stem Cell Jungle with Albert Hwa

    CAR-macrophages – a potential slippery slope ? Miriam Merad | In The Stem Cell Jungle 1:47

    CAR-macrophages – a potential slippery slope ? Miriam Merad | In The Stem Cell Jungle

    Autologous iPS Cell Therapies ? I Laurence Daheron I In the Stem Cell Jungle 1:18

    Autologous iPS Cell Therapies ? I Laurence Daheron I In the Stem Cell Jungle

    What are the specificities of cell therapy development ? | Masayo Takahashi | Stem Cell Jungle 28:55

    What are the specificities of cell therapy development ? | Masayo Takahashi | Stem Cell Jungle

    Safety & Cell Therapy Manufacturing I Laurence Daheron I In the Stem Cell Jungle 1:22

    Safety & Cell Therapy Manufacturing I Laurence Daheron I In the Stem Cell Jungle

    How does 3D organization influence stem cell differentiation ? | In the Stem Cell Jungle 3:16

    How does 3D organization influence stem cell differentiation ? | In the Stem Cell Jungle

    Transplanting Pancreatic Progenitors Vs Mature β-Cells - In the Stem Cell Jungle - Albert Hwa 1:43

    Transplanting Pancreatic Progenitors Vs Mature β-Cells - In the Stem Cell Jungle - Albert Hwa

    Stem cell therapies: public funding strategies in EU vs US vs Japan I In the Stem Cell Jungle 2:12

    Stem cell therapies: public funding strategies in EU vs US vs Japan I In the Stem Cell Jungle

    How promising are the most recent results of cell therapies for Parkinson’s disease ? 2:12

    How promising are the most recent results of cell therapies for Parkinson’s disease ?

    How can patients discern a scam from a legitimate stem cell therapy program ? Stephen Sullivan 1:58

    How can patients discern a scam from a legitimate stem cell therapy program ? Stephen Sullivan

    Why so much money is invested in cell therapies ? In the Stem Cell Jungle 5:31

    Why so much money is invested in cell therapies ? In the Stem Cell Jungle

    Encapsulating pluripotent stem cells: why ? 1:05

    Encapsulating pluripotent stem cells: why ?

    Stem Cell Therapy for Diabetes: Allogeneic vs Autologous ? In the Stem Cell Jungle l Albert Hwa 1:47

    Stem Cell Therapy for Diabetes: Allogeneic vs Autologous ? In the Stem Cell Jungle l Albert Hwa

    What are the limitations of the C-Stem™ platform? 2:13

    What are the limitations of the C-Stem™ platform?

    iPS Cell Culture : Hypoxic Conditions ? I Laurence Daheron I In the Stem Cell Jungle 1:23

    iPS Cell Culture : Hypoxic Conditions ? I Laurence Daheron I In the Stem Cell Jungle

    iPS cell safety : the Oncopanel Test I Laurence Daheron I In the Stem Cell Jungle 1:19

    iPS cell safety : the Oncopanel Test I Laurence Daheron I In the Stem Cell Jungle

    Cell therapy for Parkinson's disease: Are rodent studies sufficient before clinical trials ? 1:45

    Cell therapy for Parkinson's disease: Are rodent studies sufficient before clinical trials ?